UCP2 and pancreatic ductal adenocarcinoma: UCP2 was found to function crucially in pancreatic ductal adenocarcinoma (PDAC), and that UCP2 silencing reduces glutaminolysis and nicotinamide adenine dinucleotide phosphate (NADPH) production in P DAC cell lines, ultimately affecting tumor growth (Raho et al., 2020).